Reuters -- British inhaled-drug specialist Consort Medical (CSRT.L) reported a 33 percent drop in first-half pretax profit, hurt by special costs, but said it was comfortable with market expectations for the full year.
Reuters -- British inhaled-drug specialist Consort Medical (CSRT.L) reported a 33 percent drop in first-half pretax profit, hurt by special costs, but said it was comfortable with market expectations for the full year.
